Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial.

MLA

Leventogiannis, Konstantinos, et al. “Toward Personalized Immunotherapy in Sepsis: The PROVIDE Randomized Clinical Trial.” Cell Reports. Medicine, vol. 3, no. 11, Nov. 2022, p. 100817. EBSCOhost, https://doi.org/10.1016/j.xcrm.2022.100817.

APA

Leventogiannis, K., Kyriazopoulou, E., Antonakos, N., Kotsaki, A., Tsangaris, I., Markopoulou, D., Grondman, I., Rovina, N., Theodorou, V., Antoniadou, E., Koutsodimitropoulos, I., Dalekos, G., Vlachogianni, G., Akinosoglou, K., Koulouras, V., Komnos, A., Kontopoulou, T., Prekates, A., Koutsoukou, A., … Giamarellos-Bourboulis, E. J. (2022). Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial. Cell Reports. Medicine, 3(11), 100817. https://doi.org/10.1016/j.xcrm.2022.100817

Chicago

Leventogiannis, Konstantinos, Evdoxia Kyriazopoulou, Nikolaos Antonakos, Antigone Kotsaki, Iraklis Tsangaris, Dimitra Markopoulou, Inge Grondman, et al. 2022. “Toward Personalized Immunotherapy in Sepsis: The PROVIDE Randomized Clinical Trial.” Cell Reports. Medicine 3 (11): 100817. doi:10.1016/j.xcrm.2022.100817.